Mitsubishi Electric Corporation (TOKYO:6503) announced today that it will provide its innovative proton beam therapy system for cancer treatment to the Hakuhokai Group healthcare organization led by Chairman Motohisa Kojo in Osaka, Japan. The system will be installed at the Hakuhokai Group Osaka Proton Therapy Clinic scheduled to open in April 2016.
The new system will feature a compact, single-room design that meets the growing global demand for more cost-effective proton therapy solutions. Mitsubishi Electric's decades of experience in particle therapy systems will contribute to the increased availability of innovative, efficient systems in hospitals worldwide.
Proton Beam Therapy System
Mitsubishi Electric's proton beam therapy system features the Universal Nozzle for operational efficiency and the high-dose-rate irradiation that can reduce the irradiation time. To obtain Japanese government approval of the new system in a timely manner, testing is now being performed at the Accelerator Test Facility in Mitsubishi Electric's Kobe factory. Mitsubishi Electric will provide staff training and commissioning support to facilitate the early startup of treatment.
To date, eight of the 11 facilities now conducting particle therapy in Japan are using systems delivered by Mitsubishi Electric. More than 16,000 patients have so far been treated at these facilities. The Hakuhokai Group order, which was preceded by a separate order two weeks earlier from Tsuyama Chuo Hospital in Okayama, Japan, will become the tenth installation of a Mitsubishi Electric particle therapy system.
Top minds in multiple sclerosis to speak at CMSC 38th Annual Meeting